Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
Compare

AFIB vs. UTRS, MOTS, DRTSW, BDMDW, and COCHW

Should you buy Acutus Medical stock or one of its competitors? Acutus Medical's main competitors and comparable companies include Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), and Envoy Medical (COCHW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Acutus Medical compare to Minerva Surgical?

Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Minerva Surgical N/A N/A N/A

Acutus Medical has a beta of 5.73, indicating that its stock price is 473% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.41, indicating that its stock price is 141% more volatile than the broader market.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Minerva Surgical Neutral

Minerva Surgical has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Motus GI has higher earnings, but lower revenue than Acutus Medical. Motus GI is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Motus GI has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, indicating that its share price is 473% more volatile than the broader market.

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Acutus Medical (NASDAQ:AFIB) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Alpha Tau Medical has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Alpha Tau Medical Neutral
Acutus Medical Neutral

Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Alpha Tau Medical and Acutus Medical tied by winning 3 of the 6 factors compared between the two stocks.

How does Acutus Medical compare to Baird Medical Investment?

Acutus Medical (NASDAQ:AFIB) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Baird Medical Investment has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Baird Medical Investment$24.49MN/AN/AN/AN/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Baird Medical Investment Neutral

Baird Medical Investment has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Baird Medical Investment's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Baird Medical Investment N/A N/A N/A

Summary

Baird Medical Investment beats Acutus Medical on 4 of the 6 factors compared between the two stocks.

How does Acutus Medical compare to Envoy Medical?

Envoy Medical (NASDAQ:COCHW) and Acutus Medical (NASDAQ:AFIB) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

Envoy Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Envoy Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy MedicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Envoy Medical has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$207KN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Envoy Medical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Envoy Medical Neutral
Acutus Medical Neutral

Summary

Envoy Medical and Acutus Medical tied by winning 3 of the 6 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3K$5.57B$7.22B$12.88B
Dividend YieldN/A1.78%2.55%9.95%
P/E Ratio0.0024.83271.7925.29
Price / SalesN/A71.76709.75113.08
Price / CashN/A32.7877.5552.32
Price / BookN/A6.0010.636.26
Net Income-$81.66M$150.94M$3.48B$357.86M

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.80
+1.1%		N/A+1,176.7%$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.04
flat		N/A-55.4%$0.00$22.54MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 9/10/2026 by MarketBeat.com Staff.
From Our Partners
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
100% overnight gains?
Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...
The Oxford Club | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
Jon Najarian's #1 Energy Trade for 2026
Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...
Banyan Hill Publishing | Sponsoredtc pixel
Gold majors have a big problem
Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...
Golden Portfolio | Sponsoredtc pixel